When he got the $400,000 investment from Peter Thiel, Matthew Scholz was even more determined that he was doing the right thing. “Peter likes to go out of his way and vote for companies that look more controversial, like us.†This is the first angel investment that Immusoft got seven years ago. Seven years later, Matthew Scholz performed a roadshow at the Silicon Valley Summit in Shenzhen. As a representative of the medical technology sector, Immusoft about to start ten million B round of financing. Among the six all-English roadshow teams from Silicon Valley, Immusoft is the only company that uses Chinese PPT. Matthew Scholz on the stage was energetic and introduced the biotech company that planned to turn the human body into a pharmaceutical factory. Programming the immune system Immusoft's core business sounds crazy to incredible: Immune System Programming. As shown, this technology is divided into five main steps: Immusoft 1. Collect and isolate immune cell B cells from the patient; 2. Mediate DNA entry into isolated B cells by electroporation. Anesthesia Medical Co., Ltd. , https://www.medicaldiverse.com
